All patients with suspected channelopathy
"For athletes with a suspected/diagnosed cardiac channelopathy, a comprehensive evaluation by a heart rhythm specialist or genetic cardiologist with sufficient experience and expertise with these disorders is recommended."
(Class I Recommendation; Level of Evidence C)
Sympatomatic with suspected/diagnosed channelopathy
"It is recommended that symptomatic athletes with any suspected or diagnosed cardiac channelopathy be restricted from all competitive sports until a comprehensive evaluation has been completed, the athlete and his or her family are well informed, a treatment program has been implemented, and the athlete has been asymptomatic on therapy for 3 months."
(Class I Recommendation; Level of Evidence C)
Need to know:
⇙
⇘
Asymptomatic, Genotype + / Phenotype -
"It is reasonable for an asymptomatic athlete with genotype-positive/phenotype-negative (ie, concealed channelopathy) LQTS, CPVT, BrS, early repolarization syndrome, idiopathic ventricular fibrillation, or short-QT syndrome to participate in all competitive sports with appropriate precautionary measures, including
(Class IIa Recommendation; Level of Evidence C)
History of symptomatic or electrographically manifest Brugada syndrome
"Competitive sports participation may be considered for an athlete with either previously symptomatic or electrocardiographically evident BrS, early repolarization syndrome, or short-QT syndrome assuming appropriate precautionary measures and disease-specific treatments are in place and that the athlete has been asymptomatic on treatment for at least 3 months.
"If therapy includes an ICD, refer to the Task Force 9 report."
(Class IIb Recommendation; Level of Evidence C)
Reference: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies.
A Scientific Statement From the AHA and ACC. Circulation 2015
Disclaimer: This website is derived from published guidelines, but does not constitute medical advice
nor does it replace clinical judgement.
Only the text in quotation marks are direct quotations from the original guidelines.
Text not in quotations as well as the method of information display are all that of the
website creator and are not part of the original published guidelines.
Please consult a physician to discuss any patient-specific matters.
Key: BrS = Brugada syndrome, ICD = implantable cardioverter defibrillator